(2S, 4R)-4-[18F]Fluoroglutamine for In vivo PET Imaging of Glioma Xenografts in Mice: an Evaluation of Multiple Pharmacokinetic Models

Maxwell WG Miner, Heidi Liljenbäck, Jenni Virta, Joni Merisaari, Vesa Oikonen, Jukka Westermarck, Xiang-Guo Li, Anne Roivainen

Research output: Contribution to journalArticleScientificpeer-review

3 Citations (Scopus)

Abstract

The glutamine analogue (2S, 4R)-4-[18F]fluoroglutamine ([18F]FGln) was investigated to further characterize its pharmacokinetics and acquire in vivo positron emission tomography (PET) images of separate orthotopic and subcutaneous glioma xenografts in mice.
Original languageEnglish
Pages (from-to)969-978
Number of pages10
JournalMolecular Imaging and Biology
Volume22
Issue number4
DOIs
Publication statusPublished - 2020
MoE publication typeA1 Journal article-refereed

Fingerprint Dive into the research topics of '(2S, 4R)-4-[18F]Fluoroglutamine for In vivo PET Imaging of Glioma Xenografts in Mice: an Evaluation of Multiple Pharmacokinetic Models'. Together they form a unique fingerprint.

Cite this